GPT and fatty liver disease: Consistently, we demonstrated that patients with MAFLD had significantly higher BMI, WC, ALT, AST, γ-GT, TG, FINS, HOMA-IR, and CRP levels as well as increased proportions of obesity, hypertension, hyperlipidemia, IR, hepatic steatosis, and fibrosis compared with those without MAFLD in both genders.